Literature DB >> 19204026

Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months.

L Alvarez1, R Macias, N Pavón, G López, M C Rodríguez-Oroz, R Rodríguez, M Alvarez, I Pedroso, J Teijeiro, R Fernández, E Casabona, S Salazar, C Maragoto, M Carballo, I García, J Guridi, J L Juncos, M R DeLong, J A Obeso.   

Abstract

BACKGROUND: Stereotactic thermocoagulative lesions of the subthalamic nucleus (STN) have been shown to induce significant motor improvement in patients with Parkinson's disease (PD). PATIENTS AND METHODS: 89 patients with PD were treated with unilateral subthalamotomy. 68 patients were available for evaluations after 12 months, 36 at 24 months and 25 at 36 months.
RESULTS: The Unified Parkinson's Disease Rating Scale (UPDRS) motor scores improved significantly contralaterally to the lesion in the "off" and "on" states throughout the follow-up, except for the "on" state at the last evaluation. Axial features and signs ipsilateral to the lesion progressed steadily throughout the study. Levodopa daily doses were significantly reduced by 45%, 36% and 28% at 12, 24 and 36 months post-surgery. 14 patients (15%) developed postoperative hemichorea-ballism which required pallidotomy in eight. These 14 patients had significantly higher dyskinesia scores (levodopa induced) preoperatively than the entire cohort.
CONCLUSION: Unilateral subthalamotomy was associated with significant and sustained motor benefit contralateral to the lesion. Further work is needed to ascertain what factors led to severe, persistent chorea-ballism in a subset of patients. Subthalamotomy may be considered an option in circumstances when deep brain stimulation is not viable.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19204026     DOI: 10.1136/jnnp.2008.154948

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

Review 1.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 2.  Milestones in research on the pathophysiology of Parkinson's disease.

Authors:  Thomas Wichmann; Mahlon R DeLong; Jorge Guridi; Jose A Obeso
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

3.  Deep-Brain Stimulation for Basal Ganglia Disorders.

Authors:  Thomas Wichmann; Mahlon R Delong
Journal:  Basal Ganglia       Date:  2011-07-01

4.  Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease.

Authors:  Paul S Fishman; Victor Frenkel
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

5.  Once STN DBS, Always STN DBS?-Clinical, Ethical, and Financial Reflections on Deep Brain Stimulation for Parkinson's Disease.

Authors:  Marwan Hariz
Journal:  Mov Disord Clin Pract       Date:  2016-02-11

6.  Functional impact of subthalamotomy by magnetic resonance-guided focused ultrasound in Parkinson's disease: a hybrid PET/MR study of resting-state brain metabolism.

Authors:  Rafael Rodriguez-Rojas; Jose A Pineda-Pardo; Raul Martinez-Fernandez; Rosalie V Kogan; Carlos A Sanchez-Catasus; Marta Del Alamo; Frida Hernández; Lina García-Cañamaque; Klaus L Leenders; Jose A Obeso
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-08       Impact factor: 9.236

7.  Modulation of subthalamic T-type Ca(2+) channels remedies locomotor deficits in a rat model of Parkinson disease.

Authors:  Chun-Hwei Tai; Ya-Chin Yang; Ming-Kai Pan; Chen-Syuan Huang; Chung-Chin Kuo
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

8.  Relative contributions of local cell and passing fiber activation and silencing to changes in thalamic fidelity during deep brain stimulation and lesioning: a computational modeling study.

Authors:  Rosa Q So; Alexander R Kent; Warren M Grill
Journal:  J Comput Neurosci       Date:  2011-10-05       Impact factor: 1.621

Review 9.  Focused Ultrasound and Other Lesioning Therapies in Movement Disorders.

Authors:  Hannah Walters; Binit B Shah
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-03       Impact factor: 5.081

Review 10.  Update on models of basal ganglia function and dysfunction.

Authors:  Mahlon DeLong; Thomas Wichmann
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.